ProMIS Neurosciences Presents at the 2022 American Academy of Neurology Annual Meeting
ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today that it has presented at the American Academy of Neurology (AAN) Annual Meeting held at the Washington State Convention Center in […]
Continue Reading